go-v.orgdoi

An update on the genomic landscape of breast cancer: new opportunity for personalized therapy?

Anneleen Daemen · Translational Cancer Research · 2012

  • DOI 10.21037/588
  • Publisher AME Publishing Company
  • Type article
  • Issued 2012

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Translational Cancer Research · AME Publishing Company · article · 2012

Abstract

Breast cancer is a clinically and genomically heterogeneous disease, and may therefore benefit from personalized therapeutic strategies. Incorporating genomic information obtained by molecular analysis of an individual patient’s tumor into treatment decisions is a promising area of focus. This approach requires knowledge of the genomic landscape and its possible therapeutic implications, but will ultimately allow employing investigational therapeutic compounds in a more intelligent way. Many institutes worldwide have contributed to the genomic landscaping of breast cancer, of which the results of six studies were recently published in Nature.

These studies, summarized in Table 1, differ in breast cancer spectrum covered, primary focus, and technology platforms used. Integrating the genomic data from these studies, which is the focus of this review, provides an unprecedented opportunity to better understand the substantial variation in drug response and clinical outcome and to rethink treatment strategy.

Open the resolved locator · 10.21037/588

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 02:22 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://tcr.amegroups.com/article/viewFile/588/pdf
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.